Treatments
Interventions discussed in mitochondrial and longevity care—mechanism, human evidence and real-world risk.
Therapeutic plasma exchange and mitochondrial health
Evidence, mechanisms, risks and limits of therapeutic plasma exchange for mitochondrial and healthy-aging claims.
Read article →EBOO and mitochondrial health: evidence review
An evidence-first review of extracorporeal blood oxygenation and ozonation, mitochondrial claims and clinical risks.
Read article →Plaquex and mitochondrial health: evidence review
What membrane biology does—and does not—show about intravenous phosphatidylcholine and mitochondrial function.
Read article →Molecular hydrogen inhalation and mitochondria
Human evidence, proposed mitochondrial mechanisms, device claims, safety and regulatory status for molecular hydrogen inhalation.
Read article →Hyperbaric oxygen therapy and mitochondria
A condition-specific review of hyperbaric oxygen, mitochondrial signaling, motor-control evidence, safety and regulation.
Read article →Red, near-infrared and far-infrared therapy
What photobiomodulation and far-infrared heat evidence shows about mitochondria, performance, safety and device claims.
Read article →Pulsetto review: vagus stimulation and mitochondria
Device-specific evidence, mitochondrial claims, regulation, safety and conflicts for the Pulsetto wellness device.
Read article →NAD+ supplementation: what the evidence actually shows
Oral, liposomal, IV and injected NAD+ assessed against human mitochondrial endpoints—not blood biomarkers alone.
Read article →NR (nicotinamide riboside): the human trial record
Dose-response, muscle, metabolic, cardiovascular and brain outcomes—separated from mitochondrial marketing.
Read article →Methylene Blue: Oral vs. IV — What the Evidence Actually Shows
Methylene blue’s mitochondrial mechanism is unusually well-mapped, but human evidence is thin outside methemoglobinemia and one bipolar trial. Oral vs. IV uses, safety, and evidence grades.
Read article →